-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Recognized as a Leading Force in China’s High-Quality Pharmaceutical Development
Category:
发布时间：2022-05-04
【概要描述】
On April 28, the 33rd National Pharmaceutical Economic Information Conference and the 2021 Pharmaceutical Economic Person of the Year Awards Ceremony were held online, under the guidance of the Southern Institute of Pharmaceutical Economics of the National Medical Products Administration and organized by the Pharmaceutical Economic Daily. Following multiple rounds of rigorous selection, Shijiazhuang Sihua Pharmaceutical was recognized as a Leading Force in the Industry—Enterprise Achieving High-Quality Development in China’s Pharmaceutical Sector (2021 Top Company).
On April 28, the 33rd National Pharmaceutical Economic Information Conference and the 2021 Pharmaceutical Economic Person of the Year Awards Ceremony were held online, under the guidance of the Southern Institute of Pharmaceutical Economics of the National Medical Products Administration and organized by the Pharmaceutical Economic News. Following multiple rounds of rigorous selection, Shijiazhuang Sihua Pharmaceutical was recognized as a Leading Force in the Industry—Enterprise Achieving High-Quality Development in China’s Pharmaceutical Sector (2021 Top Company).
In 2021, as the nation’s 14th Five-Year Plan was launched, the pharmaceutical industry entered a new stage of high-quality development. Healthcare reform has now entered deeper waters, with policy initiatives such as drug review reform and volume-based procurement compelling the industry to further upgrade its innovation. Meanwhile, the momentum of digital transformation is reshaping the industry’s new ecosystem—including drug R&D, supply-chain management, prescription circulation, and online healthcare—making adherence to fundamentals while pursuing innovation the only viable path for China to advance toward becoming a global leader in the pharmaceutical sector. Under the national strategy of “innovation-driven development,” innovative resources are increasingly concentrated, and innovation capacity continues to strengthen. A cohort of outstanding companies is emerging as pioneers, practitioners, and leaders in China’s pharmaceutical industry. Shijiazhuang Sihua Pharmaceutical stands out as a prominent representative, leveraging innovation as its driving force to continuously propel the company toward the high end of the industry and to serve as a key engine for the growth of leading firms.
According to reports, in 2021 the Pharmaceutical Economic Daily used “leading strength” as its key theme and evaluated enterprises based on dimensions such as “international recognition, operational stability index, performance indicators, and social responsibility index,” thereby selecting the “Leading Forces: China’s High-Quality Pharmaceutical Development Achievements Enterprises (2021)” and recognizing industry leaders who remain committed to their original mission while pioneering new frontiers.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091